Elkfork Partners’s AMAG Pharmaceuticals AMAG Stock Holding History

Elkfork Partners’s Portfolio AMAG Stock Details AMAG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$120K	Buy	10,428 +2,398	+30%	+$25.2K	﹤0.01%	923
2019 Q2	$80K	Buy	8,030 +1,958	+32%	+$21.1K	﹤0.01%	971
2019 Q1	$78K	Hold	6,072	–	–	﹤0.01%	951
2018 Q4	$92K	Hold	6,072	–	–	﹤0.01%	904
2018 Q3	$122K	Hold	6,072	–	–	﹤0.01%	936
2018 Q2	$118K	Hold	6,072	–	–	﹤0.01%	892
2018 Q1	$122K	Buy	6,072 +792	+15%	+$13.4K	﹤0.01%	905
2017 Q4	$70K	Buy	5,280 +1,188	+29%	+$17.9K	﹤0.01%	968
2017 Q3	$76K	Buy	4,092 +1,122	+38%	+$20.9K	﹤0.01%	941
2017 Q2	$55K	Buy	2,970 +1,540	+108%	+$30.5K	﹤0.01%	958
2017 Q1	$32K	Buy	1,430 +66	+5%	+$1.58K	﹤0.01%	964
2016 Q4	$47K	Buy	+1,364	New	+$40.8K	﹤0.01%	886

Other funds holding AMAG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Elkfork Partners's AMAG Position: Q3 2019 in Review

Elkfork Partners increased its AMAG Pharmaceuticals (AMAG) stake by 30% in Q3 2019, buying an estimated $25.2K and bringing the position to 10,428 shares worth $120K. The position accounts for ﹤0.01% of the portfolio, ranked #923.

Elkfork Partners first reported a position in AMAG in Q4 2016 and has held it in 12 quarters since. The position peaked at $122K in Q3 2018. 156 funds tracked by Wall St. Rank hold AMAG as of Q3 2019.

Elkfork Partners held 10,428 shares of AMAG Pharmaceuticals worth $120K as of Q3 2019.
Elkfork Partners bought 2,398 AMAG Pharmaceuticals shares in Q3 2019, an estimated $25.2K.
AMAG Pharmaceuticals made up ﹤0.01% of Elkfork Partners's portfolio in Q3 2019, its #923 holding.
Elkfork Partners first reported a position in AMAG Pharmaceuticals in Q4 2016 and has held it in 12 quarters since.
Elkfork Partners's AMAG Pharmaceuticals position peaked at $122K in Q3 2018.
156 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q3 2019.

Based on Elkfork Partners's 13F filing for Q3 2019, filed 14 Nov 2019.